Your browser doesn't support javascript.
loading
Thrombogenicity assessment of perfusable tissue engineered constructs: a systematic review.
Haderer, Luna Maria; Zhou, Yijun; Tang, Peter; Daneshgar, Assal; Globke, Brigitta; Krenzien, Felix; Reutzel-Selke, Anja; Weinhart, Marie; Pratschke, Johann; Sauer, Igor M; Hillebrandt, Karl Herbert; Keshi, Eriselda.
Afiliação
  • Haderer LM; Charité Universitätsmedizin Berlin, Berlin, Berlin, Germany; luna-maria.haderer@charite.de.
  • Zhou Y; Charite Universitatsmedizin Berlin, Berlin, Berlin, Germany; yijun.zhou@charite.de.
  • Tang P; Charité - Campus Virchow, General-, Visceral-, and Transplantation Surgery, Berlin, Germany; Peter.Tang@charite.de.
  • Daneshgar A; Charite Universitatsmedizin Berlin, Berlin, Berlin, Germany; assal.daneshgar@charite.de.
  • Globke B; Charite Universitatsmedizin Berlin, Berlin, Berlin, Germany; brigitta.globke@charite.de.
  • Krenzien F; Charite Universitatsmedizin Berlin, Berlin, Berlin, Germany; felix.krenzien@charite.de.
  • Reutzel-Selke A; Charité - Campus Virchow, General-, Visceral-, and Transplantation Surgery, Augustenburger Platz 1, Berlin, Germany, 13353; anja.selke@charite.de.
  • Weinhart M; Free University of Berlin, Berlin, Berlin, Germany; marie.weinhart@fu-berlin.de.
  • Pratschke J; Charité - Universitätsmedizin Berlin, General, Visceral, and Transplantation Surgery, Berlin, Germany; johann.pratschke@charite.de.
  • Sauer IM; Charité, General, Visceral and Transplantation Surgery, Augustenburger Platz 1, Berlin, Germany, 13353; igor.sauer@charite.de.
  • Hillebrandt KH; Charité - Campus Virchow, General-, Visceral-, and Transplantation Surgery, Augstenburgerplatz 1, Berlin, Germany, 13353; Karl-Herbert.Hillebrandt@charite.de.
  • Keshi E; Charité Universitätsmedizin Berlin, Chirurgische Klinik, Augustenburger Platz 1, Berlin, Germany, 13353; eriselda.keshi@charite.de.
Article em En | MEDLINE | ID: mdl-39007511
ABSTRACT
Vascular surgery faces a critical demand for novel vascular grafts that are biocompatible and thromboresistant. This urgency particularly applies to bypass operations involving small caliber vessels. In the realm of tissue engineering, the development of fully vascularized organs holds great promise as a solution to organ shortage for transplantation. To achieve this, it is imperative to (re-)construct a biocompatible and non-thrombogenic vascular network within these organs. In this systematic review, we identify, classify and discuss basic principles and methods used to perform in vitro/ex vivo dynamic thrombogenicity testing of perfusable tissue engineered organs and tissues. We conducted a pre-registered systematic review of studies published in the last 23 years according to PRISMA-P Guidelines, comprising a systematic data extraction, in-depth analysis and risk of bias assessment of 116 included studies. We identified shaking (n=28), flow loop (n=17), ex vivo (arterio-venous shunt, n=33) and dynamic in vitro models (n=38) as main approaches for thrombogenicity assessment. This comprehensive review unveils a prevalent lack of standardization and serves as a valuable guide in the design of standardized experimental setups.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Tissue Eng Part B Rev Assunto da revista: BIOTECNOLOGIA / HISTOLOGIA Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Tissue Eng Part B Rev Assunto da revista: BIOTECNOLOGIA / HISTOLOGIA Ano de publicação: 2024 Tipo de documento: Article